SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-044191
Filing Date
2017-07-06
Accepted
2017-07-06 18:15:02
Documents
1
Period of Report
2017-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9985
  Complete submission text file 0001209191-17-044191.txt   11325
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Issuer) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Wiezorek Jeffrey (Reporting) CIK: 0001610823 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36508 | Film No.: 17953465